Proteomics is one of our favorite branches of biotechnology mainly due to the healthy mix of molecular biology, biochemistry, and genetics. Analyzing the structure, function, and interactions of proteins that are produced by the genes is starting to open up alot of new innovative approaches to solving problems that have plagued us for centuries.
proteomics and genomics are amazing studies that change our world. Many people that are in science study things without even knowing about this stuff, about DNA: the "script" of life. Often times, studying DNA and it's structure opens us up to a world of other studies within biology, such as proteomics and genomics. If only the structure of DNA could dictate our personal human behavior. I recommend a great Biology book: Biology ninth edition (Raven, Johnson, Mason, Losos, Singer)
It seems like one potential profit center for such a detailed blood analysis could be the testing of donated blood to check if there are various diseases in the blood in order to reduce the possibility of inadvertently transmitting diseases via blood transfusions. It could also potentially increase the number of willing donors, if a benefit of donating was that their blood could be tested for these various diseases and cancers and they could get a detailed report in exchange for their donation.
Balance / homeostasis is not strictly an Ayurvedic concept, it is present in Traditional Chinese Medicine and certainly other ancient medical systems. If Hillis is correct, doctors could be rendered obsolete (just like lawyers could be today with legal process trees). Unfortunately, biology is the poster child of a complex system, perhaps more than financial markets (which operate primarily on psychology, which is driven by several top-down inculcation mechanisms like the media).
Hillis dissection of cancer as a non-localized, systemic process ("verb") is actually very iconoclastic and problematic for the drug and cancer industry folks at the ACS, AMA, and FDA. Cancer becomes a problem when the immune system fails to phagocytize cells with perturbed cell cycles.
